Document ID: chunk:federal_register_of_legislation:F2025L00049:clause:10_15
Version: federal_register_of_legislation:F2025L00049
Segment Type: clause
Provision Reference: sch 10 cl 15
Character Range: 454339–455196

15                                HUMAN BLOOD PRODUCTS including:
                                  (a) whole blood;
                                  (b) blood components including red cells, white cells, platelets and plasma (including cryoprecipitate); and
                                  (c) the following plasma‑derived therapeutic proteins; and their equivalent recombinant alternatives:
                                  (i) albumin;
                                  (ii) anticoagulation complex;
                                  (iii) C1 esterase inhibitors;
                                  (iv) clotting factors;
                                  (v) fibrinogen;
                                  (vi) protein C;
                                  (vii) prothrombin complex concentrate (PCC);
                                  (viii) thrombin